CN1199617A - Chinese patent drug for eye disease - Google Patents

Chinese patent drug for eye disease Download PDF

Info

Publication number
CN1199617A
CN1199617A CN96114392A CN96114392A CN1199617A CN 1199617 A CN1199617 A CN 1199617A CN 96114392 A CN96114392 A CN 96114392A CN 96114392 A CN96114392 A CN 96114392A CN 1199617 A CN1199617 A CN 1199617A
Authority
CN
China
Prior art keywords
eye
medicine
composition
rhizoma
calomelas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN96114392A
Other languages
Chinese (zh)
Inventor
虎发光
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN96114392A priority Critical patent/CN1199617A/en
Publication of CN1199617A publication Critical patent/CN1199617A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The Chinese properietary medicine is a kind of eye drops prepared with Chinese medicinal materials including Rhizoma Coptidis, Rhizoma Ligustici Chuanxiong, borax, smithsonite, calomelas and borneol and liquid paraffin wax. It can cure epiphora induced by wind, red and swollen eye, nebula and other eye diseases. It has wide application range, determined cure effect and no toxic side effect.

Description

A kind of Chinese patent medicine for the treatment of oculopathy
The present invention relates to a kind of external Chinese patent medicine that ophthalmic diseases is the master for the treatment of.Especially elimination eyes epiphora induced by wind, red and swollen heat pain, nebula hypertrophy there is unique curative effect.
Disease of eye is generally taken medicine and is absorbed meagrely, and the spongaion thickness is stuck with paste eye, and medicine can not fully be absorbed.Collyrium is too rare again, and volatilization is fast, and goes into pharyngeal cavity along the lachrymal sac pipe flow easily again, and this is the drawback that the ophthalmology medicine for external use exists for a long time.
The inventor goes through the clinical experimental study in year surplus in the of ten and sums up, and makes adjuvant with paraffin oil, and retention time is long within the eye to keep medicinal liquid.Intensive, not volatile because of the molecules align of oil, it is thick and not sticking, does not stick with paste eye, is difficult for flowing into pharyngeal cavity, can give full play to curative effect of medication, mends the deficiency with cream and water preparation eye dripping.
Main technical schemes of the present invention is: prescription: Rhizoma Coptidis, Rhizoma Chuanxiong, Borax, Calamina, Calomelas, Borneolum Syntheticum function: heat-clearing and toxic substances removing, changing stagnant making eye bright cures mainly: Fang Yi such as conjunctivitis, keratitis, trachoma, vitreous opacity: Rhizoma Coptidis, Calamina in the side, heat clearing and damp drying, eliminating fire and detoxication, the convergence arresting lacrimation; Borneolum Syntheticum, the pain relieving of Borax putrefaction removing, improving acuity of vision and removing nebula; The Calomelas granulation promoting is antipruritic, removes bulbar conjunctiva polyp; Rhizoma Chuanxiong blood circulation promoting and blood stasis dispelling, removing obstruction in the collateral to relieve pain, all medicines share to reach jointly eliminates eyes epiphora induced by wind, red and swollen heat pain, illness such as nebula hypertrophy.Also to suppurative otitis media, skin ulcer etc. also have unique therapeutical effect simultaneously.
Followingly according to the prescription among the present invention two embodiment are disclosed: prescription: Rhizoma Coptidis 60, Rhizoma Chuanxiong 60, Calamina 100, Borax 50, Borneolum Syntheticum 16, Calomelas 3, paraffin oil 500 method for makings: earlier Calamina is ground Mo Bubao and Rhizoma Coptidis, the infiltration of Rhizoma Chuanxiong clear water, close paraffin oil then and endure out moisture content (sound being arranged) in the pot with the medicine that stirs in the oil with putting, filter with the husky cloth of bilayer and to put into after Borax, Borneolum Syntheticum, the abundant stirring and dissolving of Calomelas, in the aseptic eye dripping bottle of cool back fill, every day 3-5 time during use, every eyespot 1-2 drips.Prescription: Rhizoma Coptidis 70, Rhizoma Chuanxiong 70, Calamina 130, Borax 35, Borneolum Syntheticum 18, Calomelas 4, paraffin oil 600 method for makings: earlier Calamina is ground Mo Bubao and Rhizoma Coptidis, the infiltration of Rhizoma Chuanxiong clear water, close paraffin oil then and endure out moisture content (sound being arranged) in the pot with the medicine that stirs in the oil with putting, filter with the husky cloth of bilayer and to put into after Borax, Borneolum Syntheticum, the abundant stirring and dissolving of Calomelas, in the aseptic eye dripping bottle of cool back fill, every day 3-5 time during use, every eyespot 1-2 drips.The clinical comparison case:
Patient Li Yushan, man 56 years old, nineteen ninety-five first visit on March 12.Eyes epiphora induced by wind 6 years is surplus, the eyes congestion and swelling pain a few days does not heal whenever getting angry, found blurring of vision before March, be diagnosed as trachoma through ophthalmologic examination, vitreous opacity, the bright spongaion of frequent external, rifampicin eye drop, the Chinese medicine of heat clearing away nourishing the liver to improve visual acuity more for oral administration all produces effects not quite, likes after 1 month to accuse with this Chinese patent medicine behind the autodiagnosis and heals.
One friendly Zhao Xiao is firm, and 35 years old, first visit on June 19 in 1993, left in ear flowing water was suppurated 3 years, got angry more very whenever drinking, and department of eye diagnosing chronic otitis media was once obeyed antibiotic, and the external [is invalid.The bimester before right lower extremity crash through and more do not have the ulcer surface of 3 * 6cm not close up for a long time, and the outer trend that develops is arranged, and want to ask me to join a folk prescription, expect that this Chinese patent medicine has the functional component of convergence dampness, putrefaction-removing granulation-promoting, give 6 and allow its two place use simultaneously, happiness is accused more after 10 days.

Claims (3)

1. Chinese patent medicine for the treatment of disease of eye is characterized in that the weight proportion of following medicine, and the composition of the compositions of technology preparation and the weight portion of each composition are routinely:
Rhizoma Coptidis 60-80. Rhizoma Chuanxiong 60-80. Borax 40-50. Calamina 100-150.
Borneolum Syntheticum 16-20. Calomelas 3-5. paraffin oil 500-600.
2. according to the pharmaceutical composition of claims 1, it is characterized in that the composition of this medicine and the weight portion of each composition are:
Rhizoma Coptidis 60. Rhizoma Chuanxiongs 60 Calaminas 100 Boraxs 50.
Borneolum Syntheticum 16. Calomelass 3. paraffin oil 500.
3. according to the pharmaceutical composition of claims 1,2, it is characterized in that described its method for making is that Calamina grinds Mo Bubao and Rhizoma Coptidis, Rhizoma Chuanxiong clear water soak into, put into the fried moisture content of an amount of paraffin oil, put into an amount of Borax, Borneolum Syntheticum, Calomelas stirring and dissolving after the filtration.
CN96114392A 1996-12-18 1996-12-18 Chinese patent drug for eye disease Pending CN1199617A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN96114392A CN1199617A (en) 1996-12-18 1996-12-18 Chinese patent drug for eye disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN96114392A CN1199617A (en) 1996-12-18 1996-12-18 Chinese patent drug for eye disease

Publications (1)

Publication Number Publication Date
CN1199617A true CN1199617A (en) 1998-11-25

Family

ID=5122116

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96114392A Pending CN1199617A (en) 1996-12-18 1996-12-18 Chinese patent drug for eye disease

Country Status (1)

Country Link
CN (1) CN1199617A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1084625C (en) * 1999-12-01 2002-05-15 常毅坚 Medicine for treating ophthalmopathy
CN1294935C (en) * 2001-09-13 2007-01-17 王玉琪 Eye drop with various herb medicines and preparation thereof
CN101185687B (en) * 2007-12-11 2012-03-07 叶明伟 Fumigation and cleaning medicine for treating acute conjunctivitis
WO2012032209A2 (en) 2010-09-08 2012-03-15 Universidad Miguel Hernández De Elche Pharmaceutical composition for the treatment of dry eye
CN105663481A (en) * 2016-03-17 2016-06-15 刘冬梅 Chinese herb preparation for treating peppercorn sore

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1084625C (en) * 1999-12-01 2002-05-15 常毅坚 Medicine for treating ophthalmopathy
CN1294935C (en) * 2001-09-13 2007-01-17 王玉琪 Eye drop with various herb medicines and preparation thereof
CN101185687B (en) * 2007-12-11 2012-03-07 叶明伟 Fumigation and cleaning medicine for treating acute conjunctivitis
WO2012032209A2 (en) 2010-09-08 2012-03-15 Universidad Miguel Hernández De Elche Pharmaceutical composition for the treatment of dry eye
EP4268814A2 (en) 2010-09-08 2023-11-01 Universidad Miguel Hernández De Elche Pharmaceutical composition for the treatment of dry eye
CN105663481A (en) * 2016-03-17 2016-06-15 刘冬梅 Chinese herb preparation for treating peppercorn sore

Similar Documents

Publication Publication Date Title
JPS58172314A (en) Use of pyrrolopyrole for eye disease treatment
CN1207322A (en) Eye drops for treating conjunctivitis and preparing process thereof
CN101648004A (en) Medicinal composition for treating eye diseases and application thereof
CN107898816A (en) Eye medicinal preparation and its application
CN102357196B (en) External traditional Chinese medicine composition for treating xerophthalmia and preparation method thereof
CN1199617A (en) Chinese patent drug for eye disease
CN104546993A (en) Pharmaceutical composition for treating dark eye circles and preparation method and use thereof
CN1285349C (en) Chinese medicinal formulation for treating asthenopia syndrome and its preparation method
CN103520543B (en) Treat the Chinese medicine composition of facioplegia
CN108434219A (en) A kind of Chinese medicine composition is preparing the application in treating or preventing tympanitis drug
CN103830258A (en) Medicine prepared by using epimedium as drug effect raw material for eyes
CN1160091C (en) Medicine for treating ophthalmopathy
CN110433272A (en) A kind of pharmaceutical composition and preparation method thereof for cold-hot compression eye sticker
CN101244126A (en) Composition for treating eye disease and preparation method
CN1311842C (en) Medicine for treating chronic conjunctivitis
CN101199685B (en) Smoked washing medicament for treating chronicity conjunctivitis
CN103505562B (en) For treating the Chinese medicine of keratitis
CN104771470A (en) Medicine composition for treating postoperative complications of phacoemulsification
CN104857327A (en) Viral keratitis treating decoction drug and preparation method thereof
CN1262300C (en) Medicinal liquid for Hong Kong foot
CN100553658C (en) A kind of medicine for the treatment of dementia and preparation method thereof
CN103705803B (en) Treat cataractous Chinese medicine composition and preparation method thereof
Kularathna et al. Ayurveda Treatment Protocol in the Management of Bahala Vartma wsr to Meibomitis: A Case Study
CN106421198A (en) Novel application of Qiming (fruit of Chinese wolfberry and semen cassiae) traditional Chinese medicinal composition
CN1108130A (en) Herbal medicine prepn. for treating cataract and its prepn. method

Legal Events

Date Code Title Description
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Hu Faguang

Document name: Correction notice

C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Hu Faguang

Document name: Notice of first review

C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Hu Faguang

Document name: Deemed as a notice of withdrawal

C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Hu Faguang

Document name: payment instructions

C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication